Items tagged with Research and development
An investment case for new TB vaccines (post with simple image)
A document summarizes the results of the WHO-commissioned full value proposition for new TB vaccines.
Worldwide TB R&D funding surpasses US$1 billion, but falls short of goals (post with simple image)
A report highlights that despite reaching US$1 billion in spending in 2021, funding for TB R&D is a mere fraction of what’s needed to achieve UN sustainable development goal of ending TB as a pandemic by 2030.
Act now: A call to world leaders to increase investment in TB vaccine R&D (post with simple image)
Global TB community calls on world leaders to increase political and financial commitments to develop and roll out new TB vaccines as a central part of the global TB response.
Wellcome and the Gates Foundation to fund late-stage development of a TB vaccine candidate (post with simple image)
Wellcome and the Bill & Melinda Gates Foundation announce US$550 million funding to advance a TB vaccine candidate, M72/AS01E, through a Phase III clinical trial that could be the first in 100 years if proven effective.
Investment toolbox to advance TB vaccine development through joint action (post with simple image)
A policy brief outlines recommendations for G20 members to act together to accelerate TB vaccine development.
Member States must commit to invest in TB vaccine R&D (post with simple image)
A one-pager, developed by TB Vax ARM, provides relevant background information on the critical need for Member States to substantially increase adequate, predictable, and sustainable financing for TB vaccine research.
Information note: New fair share funding targets for TB research 0.1% -> 0.15% (post with simple image)
Treatment Action Group releases an updated Information note providing details on the new 0.15% fair share funding targets for TB research.
Nearly all countries “far off track” of meeting TB research targets despite publicly reaffirming commitments at UN (post with simple image)
A sobering new analysis from Treatment Action Group shows that governments failed to meet previous commitments to fund TB research.
TAG's 2023 Pipeline Report: TB vaccines (post with simple image)
Treatment Action Group launches the first TB chapter of its 2023 Pipeline Report.
TAG condemns GSK actions surrounding potential TB vaccine revealed by bombshell ProPublica report (post with simple image)
The report portrays how GSK’s financial interests have – and will likely continue to – set back progress against the world’s deadliest infectious disease lays bare just how egregiously large pharmaceutical companies bilk the global public, and makes an urgent case for government and philanthropic funders to take action and demand better.
Page 27 of 28 · Total posts: 0
←First 26 27 28 Last→